INTRODUCTION
Previously, we described the development of a monoclonal antibody (designated mAb213-21) raised against the InsP $ -sensitive internal dense-tubular-system membranes of platelets, and which inhibited Ca# + release by InsP $ from internal membrane vesicles derived from platelets, cerebellum, smooth muscle, sea urchin eggs and from HEL cells, a human leukemic cell line with megakaryoblastic features [1, 2] . The antibody did not react with the InsP $ receptor protein on Western blots. Its effect on Ca# + release was mimicked by certain K + channel blockers and reversed by K + ionophores, suggesting that the antibody affected a K + conductance [2] . These effects of K + channel blockers and ionophores on Ca# + release from the ER were later confirmed in intact cells by Nguyen et al. [3] . The antibody-binding protein in both platelets and HEL cells is an integral membrane protein localized to the smooth endoplasmic reticulum (ER) fraction of cell homogenates.
Here we report the cloning and sequencing of a novel cDNA obtained by screening a human HEL cell cDNA expression library with mAb213-21, the predicted amino acid sequence of the protein, designated CHERP (Ca# + homoeostasis endoplasmic reticulum protein), the mapping of the gene to human chromosome 19p13.1, the tissue expression of its mRNA, and the Abbreviations used : CHERP, Ca 2 + homoeostasis endoplasmic reticulum protein ; [Ca 2 + ] i , cytosolic free Ca 2 + concentration ; ER, endoplasmic reticulum ; GST, glutathione S-transferase ; IPTG, isopropyl β-D-thiogalactoside ; lacI, E. coli lac repressor protein ; SERCA, sarcoplasmic/endoplasmicreticulum Ca 2 + -ATPase ; TM, transmembrane domain ; HEL, human erythroleukaemia ; EST, expressed sequence tag. 1 Present address : Gerontology Division, Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, 77 Avenue Louis Pasteur, Boston, MA 02115, U.S.A. 2 To whom correspondence should be addressed (e-mail orourke!nso1.uchc.edu). 3 Present address : Department of Pharmacology, University of Pittsburgh, Pittsburgh, PA 15260, U.S.A. The nucleotide sequence data reported will appear in GSDB, DDBJ, EMBL and GenBank2 Nucleotide Sequence Databases under the accession number U94836.
and histadine octa-and nona-peptide repeats. In itro translation of the full-length cDNA produced proteins of M r 128 000 and 100 000, corresponding to protein bands detected by Western blotting of many cell types. CHERP was co-localized in HEL cells with the InsP $ receptor by two-colour immunofluorescence. Transfection of HEL cells with antisense cDNA led to an 80 % decline in CHERP within 5 days of antisense induction, with markedly decreased intracellular Ca# + mobilization by thrombin, decreased DNA synthesis and growth arrest, indicating that the protein has an important function in Ca# + homoeostasis, growth and proliferation.
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immunocytochemical localization of the protein. We describe the preparation of a stable HEL cell line transfected with an inducible antisense knockout construct of CHERP cDNA and its use to determine the effects of protein knockout on DNA synthesis, cell proliferation and thrombin-stimulated release of intracellular Ca# + stores.
MATERIALS AND METHODS

Cloning and sequencing of the CHERP cDNA from a HEL cell expression library
Standard procedures were used for library screening, recombinant DNA technology, primer extension, and Northern and Southern hybridization [4, 5] . A HEL cell lambda gt11 expression library (provided by Dr M. Poncz, University of Pennsylvania, PA, U.S.A.) [6] was screened using the monoclonal antibody 213-21, and a peroxidase-labelled secondary antibody (Boehringer Mannheim) with tetramethylbenzidine (Kirkegaard and Perry, Gaithersburg, MD, U.S.A.) as a substrate for detection of positive plaques. The mAb213-21 was harvested from hybridoma cultures growing in protein-free media (Hybrimax, Sigma). cDNA from positive plaques was subcloned as described below to generate the phage vectors pJLBS213\2.6, pJLBS213\3.9 and pJLBS213\4.0, or into M13mp8 and M13mp9 phage vectors (New England Biolabs) for sequencing. The cDNA sequence was obtained manually using a Sequenase kit 2.0 (USB, Cleveland, OH, U.S.A.) or by an automatic sequencing system (Applied Biosystems, Foster City, CA, U.S.A.) using fluorescently labelled primers. cDNAs were prepared from human cardiac and cerebellar libraries (Stratagene) and genomic DNA was prepared from a human fetal liver library (A.T.C.C.). All DNA was sequenced in both directions. The lambda DNA clones were also sequenced by a PCR sequencing system (Promega). Probes were labelled using gene-specific primers or random hexamers [4] . Sequences of the cDNA fragments were assembled using MacVector4 6.0 (IBI, New Haven, CT, U.S.A.) software and aligned with sequences in the National Center for Biotechnology Information taxonomy database using nBLAST software at a stringency of P 0.0001 [7] , or with MacVector. The predicted protein sequence was analysed for protein consensus domains, including potential membrane-spanning domains, with a Kyte-Doolittle window size l 12 [8] . The human multiple tissue Northern blot (ClonTech) was probed with a $#P-labelled 3.9 kb HEL cDNA, and with the 2.6 kb cDNA, which lacks the CAG repeat region to avoid hybridization with other CAG-containing RNAs.
Plasmid constructs
Specific details of the molecular cloning of the plasmids described herein are available from the authors on request. All in-frame cloning was verified by sequencing. The cDNA was cloned into Bluescript KS − (Stratagene) for amplification of the cDNA into the pET3 (Novagen, Madison, WI, U.S.A.) series of T7 expression vectors for in itro translation, into pGEX (Pharmacia) for expression of a glutathione S-transferase (GST)-fusion protein in Escherichia coli, and into the mammalian expression vector pOPRSVICAT (Stratagene) to make an inducible construct for the expression of CHERP antisense DNA in the AS-HEL cell line. The plasmid pJLBS213\2.6 includes a 2642 nt EcoRI insert from a lambda gt11 clone recovered by expression screening with mAb213-21. This fragment corresponds to the 4.0 kb CHERP cDNA from nt 1335 through the 3h end, but does not include nt 2290-2337, the putative alternatively spliced exon. The plasmid pJLBS213\3.9 includes the 3877 nt EcoRI fragment of CHERP, corresponding to nt 144-4018 of the 4.0 kb CHERP cDNA, including the 48 nt putative alternatively spliced exon. The plasmid pJLBS213\4.0 includes the entire 4018 nt fragment of the HEL cell CHERP cDNA. The plasmid pJLT7213\2.6 includes the 2.6 kb cDNA insert from pJLBS213\2.6 cloned in frame into pET3b. The expressed region in this vector comprises the amino acid domain from proline-417 through the C-terminus of CHERP. The plasmid pJLT7213\FL contains the Sfu1 fragment (nt 28-3393 of the 4.0 kb cDNA) cloned in frame into pET3c, and comprises the entire coding region of the HEL cell cDNA. To enable expression of a GST-fusion protein in E. coli, the 2.6 kb cDNA from pJLBS213\2.6 was cloned in-frame into pGEX-5i1 (Pharmacia), to make the plasmid pJLGST213\2.6. The mammalian expression vector pOPRSVICAT (Stratagene) was used to make an inducible construct for the expression of CHERP antisense cDNA, pJLRSV213\∆CAG.AS. The chloramphenicol acetyltransferase gene from pOPRSVICAT was replaced with the 3.9 kb EcoRI fragment from pJLBS213\3.9, inserted in the antisense orientation relative to the promoter. To eliminate inadvertent antisense knockout of other cDNAs containing extended CAG trinucleotide repeats, the 533 nt Sma1 fragment, which spanned the CAG repeat region, was subsequently deleted (corresponding to nt 683-1216 of the 4.0 kb cDNA). [9] by complete EcoRI digestion [10] . The CHERP gene was localized to chromosome 19 using gene-specific primers to PCR-amplify a human chromosome panel. A 2.6kb cDNA probe was used to screen colony filters of a chromosome 19 cosmid library [9] . Five positive cosmids, R3532, R33330, R33231, F17025 and R30560, were identified. These clones were analysed by EcoR1 digestion [10] and incorporated into the metric physical map of chromosome 19 [11] . The CHERP-positive clones were localized within a 6 mb cosmid\bacterial artificial chromosome contig in 19p13. 
In vitro expression of CHERP cDNA
The plasmids pJLT7213\2.6 and pJLT7213\FL were transcribed and translated by the mMessage mMachine4 transcription and Retic Lysate IVT4 system (Ambion, Austin, TX, U.S.A.). Transcribed mRNA was resuspended in water, and the concentration and purity were determined with a Gene Quant spectrophotometer. The rate of [$&S]methionine incorporation into protein was determined by trichloroacetic acid precipitation of aliquots of the reaction mix on glass filters as described in the kit. The translation products were separated by SDS\7.5 % PAGE followed by exposure for 4 h on a Molecular Dynamics (Sunnyvale, CA, U.S.A.) PhosphorImager screen. The GSTfusion protein prepared from plasmid pJLGST213\2.6 was expressed and purified according to the manufacturer 's specifications (Pharmacia).
Cellular localization of CHERP
Cells were plated on coverslips in culture dishes and incubated for 24-48 h to allow them to adhere. The cells were fixed in 4 % formaldehyde in PBS for 30 min at room temperature and washed three times with PBS containing 0.2 % BSA (wash buffer), followed by incubation with 20 mM glycine in PBS for 10 min. After washing once, cells were permeabilized for 30 min with 0.05 % Triton X-100 in PBS with 1 % goat serum, followed by washing and incubation for 45 min with primary antibody. The primary and secondary antibodies were diluted as described below in PBS buffer containing 0.05 % Triton X-100 (except for the thrombin-receptor antibody) and 0.1 % goat serum. The mAb213-21 was harvested from hybridomas as previously de-Cloning of CHERP, a novel Ca 2 + homoeostasis endoplasmic reticulum protein scribed [2, 13] 
Stable transfection of HEL cells
The LacSwitch mammalian cDNA expression system (Stratagene) was employed for the selective induction of RNA transcription of CHERP antisense cDNA with isopropyl β--thiogalactoside (IPTG). HEL cells adapted to Hybrimax growth media (Sigma), containing 10 % FBS (Hyclone, Logan, UT, U.S.A.) and 10 % cloning supplement (Boehringer Mannheim), were first transfected with an E. coli lac repressor (lacI) expression plasmid p3hSS, followed by selection of antibiotic resistance to hygromycin and cloning by limiting dilution. Three stably transfected HEL cell lines constitutively expressing lacI were established, and the one which displayed the highest level of antilacI immunofluorescence was used as the parent cell line for a second transfection with either the plasmid vector pOPRSVICAT (Stratagene) with a geneticin-resistance gene for selection (V-HEL cells), or the CHERP antisense plasmid pJLRSV213\ ∆CAG.AS, which carried a 3.4 kb cDNA inserted in the antisense orientation (AS-HEL cells). Both plasmids contained the lacI repressible promoter. Stable transfectants were selected for geneticin resistance and cloned as described above. Clones were expanded and weaned from cloning supplement and maintained in media containing hygromycin (200 µg\ml) and geneticin (300 µg\ml), and grown at 10 % CO # . Cells were stored at early passage in liquid nitrogen and recloned periodically. Expression of CHERP protein was quantitatively analysed by ELISA [13] , or by Western blot [13] using mAb213-21 with a peroxidaselabelled goat anti-mouse IgM as the second antibody for ECL detection (Kirkegard and Perry) and quantification by a Molecular Dynamics laser densitometer using Image Quant software.
Thymidine incorporation into DNA of transfected HEL cells
Cells were induced with IPTG for 24 h followed by washing and incubation with 10 µCi\ml [$H]thymidine [14] . Replicate cultures were set up to provide cell counts for calculation of DNA synthesis by cell number and protein content. Cells were harvested and washed with Hanks buffered salt solution, followed by fixation and washing with trichloroacetic acid. DNA was extracted with perchloric acid and assayed for [$H]thymidine by liquid-scintillation counting.
Senescence-associated β-galactosidase activity
Transfected AS-HEL and V-HEL cells were plated on coverslips and treated with 20 mM IPTG for 1-5 days. Cells were washed, fixed and assayed for senescence-associated β-galactosidase activity [15] . The coverslips were mounted with Miolol and photographed at 440i using an inverted Olympus microscope.
Ca 2 + mobilization in transfected HEL cells
HEL cells were plated out on coverslips and incubated for 24 h at 37 mC to allow adherence. The culture medium was replaced with Hepes-buffered saline [120 mM NaCl, 5.3 mM KCl, 0.8 mM MgSO % , 1.8 mM CaCl # , 5.5 mM glucose, 20 mM Hepes\NaOH (pH 7.4)] containing 2 µM fura-2 acetoxymethyl ester (Molecular Probes, Eugene, OR, U.S.A), and incubated for 30 min at 25 mC followed by washing with Hepes buffered saline. Dye-loaded cells were incubated for an additional 30 min at 25 mC, followed by washing with either Hepes-buffered saline or Ca# + -free Hepes-buffered salinej0.5 M EGTA, resuspended in 200 µl of wash buffer and viewed with a Nikon Fluor 100i1.3 NA inverted oil immersion lens. Wash buffer (800 µl) containing thrombin (final concentration 1-10 nM ; Sigma) or 1 µM thapsigargin (Sigma) was added to the chamber. Ca# + influx was measured as previously described [16] . Cells were flashed with excitation light at wavelengths of 340 nm and 380 nm alternatively, and the fluorescence emissions were collected at 510 nm using a photon counting fluorescence subsystem (Ionoptix, Milton, MA, U.S.A.). The 340\380 ratios were collected at a rate of 1 Hz. The software Ionwizard was used to collect and quantify fluorescence measurements. The magnitude of the 340\380 signal increases as a function of the rise in cytostolic free Ca# + concentration, [Ca# + ] i [17] .
RESULTS
Molecular cloning of CHERP cDNA from a HEL cell expression library
A novel 2.6 kb cDNA which included polyadenylation signals and a polyadenylated tail was initially isolated by expression screening of a lambda gt11 HEL cell library with mAb213-21. A NotI restriction fragment derived from the 5h end of the cDNA sequence was used to rescreen the library for overlapping clones. We identified 32 additional clones, including 12 with inserts of approx. 4 kb in length. The longest of these had a 4018 nt insert (Figure 1a) , which overlapped the 2.6 kb cDNA but extended further in the 5h direction. The overlapping region of the two clones was found to be identical, except for an additional stretch of 48 nt in the 4.0 kb cDNA (nt 2290-2337), suggesting that the gene contained an alternative splice site (Figure 1a ). Additional clones, obtained by screening human cerebellar and cardiac cDNA libraries and a human genomic fetal liver library, were identical with the HEL cDNA in the regions that were sequenced, except for a difference in two nucleotides in the single cerebellar clone. Primer extension of HEL cell mRNA revealed that the cDNA sequence lacked approx. 70 residues at the 5h end ( Figure  1b) . Consistent with this finding, a search of the GenBank2 revealed a homologous 1.8 kb cDNA (HSDAN26) of unknown function, derived from a human lymphoblastoid cDNA library [18] , that overlaps the 4.0 kb CHERP cDNA, but extends 46 nt beyond the 5h end of CHERP (Figure 1b) . Furthermore, a homologous expressed sequence tag (EST) R72355, derived from a human breast library, extends 39 nt beyond the 4.0 kb CHERP cDNA at the 5h end, and contains the same 5h sequence as HSDAN26, with the exception of 3 ambiguous nucleotides. We identified 156 ESTs in the GenBank2 which match the CHERP cDNA sequence, originating from human testis, brain, uterus, heart, retina, lung, skin, fetal heart and tumours derived from parathyroid, colon, endometrium, pancreas and ovary, and a variety of tissues derived from other species including rat, mouse, zebra fish. The CHERP cDNA sequence showed no significant similarity to any known gene with the exception of a region of CAG trinucleotide repeats (Figures 1a and 1c) interrupted by a single CAA, which codes for a polyglutamine tract.
The CHERP gene was localized to human chromosome 19, within an approx.1 mb region in 19p13.1, situated between the oncogenes MEL and ERBAL2. Southern blot and sequencespecific PCR data of genomic DNA are consistent with that of a single copy gene (results not shown). A single CHERP mRNA transcript of approx. 4.2 kb was found in normal human brain, placenta, lung, liver, kidney, pancreas, cardiac and skeletal muscle, and in cultured megakaryoblastic HEL and Dami cells, but cardiac and skeletal muscle had an additional transcript of 6.4 kb (Figure 2) .
The 4018 nt HEL cell CHERP cDNA sequence translated to a novel protein of 884 amino acids (Figure 1 ) with a molecular mass of 100 kDa and a calculated pI of 9.46. Similarly, the 100 kDa platelet protein, purified by a series of HPLC steps (results not shown), reacted strongly with mAb213-21 on Western blots and had a pI 9 10, as determined by isoelectric focusing. The 5h extensions of both HSDAN26 and EST R72355 include a Kozak sequence with another in-frame start codon that could potentially add 32 amino acids, or 1.6 kDa, to the CHERP sequence (Figures 1a and 1b) . In itro translation of the 4.0 kb cDNA produced a 100 kDa polypeptide (Figure 3 ) in agreement with the predicted size, and with the 100 kDa protein band detected by Western blotting in platelets and cardiac myocytes (results not shown). An additional 128 kDa product was produced, corresponding to the predominant protein band found by Western blotting of HEL cells, the other megakaryoblastic cell lines Dami, Meg-01 and CHRF-288, and of rat cerebellum (results not shown). The 2.6 kb cDNA produced a single polypeptide which also migrated on gels about 20 % larger than the expected size of 52 kDa (Figure 3) . A GST-fusion protein prepared from the 2.6 kb cDNA expressed in E. coli reacted strongly by Western blotting with mAb213-21, proving that the cDNA was inserted in the correct reading frame for protein expression, and that the epitope of the antibody binds to the region of the protein between Pro%"( to the C-terminus. This was further established by a competitive ELISA, in which the expressed GST-fusion protein effectively competed (IC &! l 0.7 µM) with the native proteins from HEL cell and platelet membranes for binding to the antibody.
The predicted protein has two domains (TM1 and TM2), based on analysis by the Kyte-Doolittle hydropathy scale, which have characteristic features of transmembrane domains of ion channels : i.e. a hydrophobic domain with a number of intermittent polar residues, and neighbouring regions with a relatively high number of charged residues. A short stretch between TM1 and TM2 is predicted to have a sheet-turn-sheet structure, which is characteristic of the pore region of many channels [19] . The sequence within this region bears some similarity to the pore of certain K + channel proteins and a two transmembrane ATPreceptor cation channel [20] , and has a signature GLG motif found in some members of the 4TM class of K + channels [21] [22] [23] .
Several regions of the predicted sequence may be involved in protein-protein binding. The first, just distal to the pore-like domain, is the polyglutamine tract (Gln#*)-Gln$!*), which corresponds to the extended CAG repeat region in the cDNA. Beyond that is a proline-rich region containing several sequences (reviewed in [24] ) known to bind Src homology domains in proteins. Immediately proximal to TM2 is an extended region of octa-or nona-peptide imperfect repeats. Commencing at Trp%#$ are seven imperfect tryptophan-repeats with a net negative charge, followed by a transition to a series of phenylalanine-repeat domains with a net positive charge, providing the entire segment from Trp%#$ to Phe&%' with an amphiphilic character. Of the amino acids from Trp%#$ to Phe&)( 15 % have aromatic side chains. Similar regions are proposed to play a role in macromolecular assembly in other proteins [25] , as are histidine repeats, such as the seven imperfect nonapeptide histidine repeats beginning at His&&%, punctuated by one heptapeptide and ending at the start of TM2. A serine\ arginine-rich region, also implicated in protein-protein binding, extends from Ser(!& to Ser()& in the C-terminus of CHERP. This region contains a total of 31 positively charged residues with no negatively charged residues, and includes many consensus sites for phosphorylation by protein kinases A and C, glycogen synthase kinase-3, and casein kinase. Potential phosphorylation sites for tyrosine kinases and protein kinase C are found outside the serine\arginine domain. In addition, the protein contains consensus sequences for glycosylation (Asp)')) and glycosaminoglycan attachment (Ser)#$GXG), and putative ER retention signals at the C-terminus (S)(#FI and D))"E) [26, 27] .
Localization of CHERP in HEL cells
CHERP was immunolocalized in HEL cells using a FITClabelled mAb213-21, and was found to be distributed throughout the cytoplasmic region ( Figure 4A ). The intracellular staining pattern of CHERP was the same as that of the InsP $ receptor, as shown by indirect fluorescence using a cyanin-3-labelled secondary antibody ( Figure 4B) , and SERCA2 and SERCA3 (results not shown). Cells that were double-labelled with green mAb213-21 and red anti-InsP $ fluoresced yellow from overlapping emission spectra, demonstrating the spatial co-localization of CHERP with the InsP $ receptor ( Figure 4C ). Figure 6D ). Furthermore, after one, three and five days of treatment of AS-HEL cells with IPTG, blue nuclear staining for senescence-associated β-galactosidase activity [15] was observed in 4 %, 26% and 67 % Cloning of CHERP, a novel Ca 2 + homoeostasis endoplasmic reticulum protein respectively of the population (Figure 7 ), compared with 6 % in the V-HEL cells treated with IPTG for 5 days.
Stable transfection of HEL cells with antisense CHERP cDNA
Intracellular Ca 2 + mobilization in HEL cells transfected with antisense cDNA
The effect of CHERP knockout on thrombin-stimulated increase in [Ca# + ] i was monitored by fluorescence microscopy in single HEL cells. Thrombin activates the phospholipase C pathway to produce InsP $ , which releases intracellular Ca# + stores in HEL cells [28] . The emptying of the stores triggers, in turn, an influx of Ca# + through the plasma membrane [16] . To specifically isolate the contribution of intracellular Ca# + mobilization from the contribution of Ca# + influx, the first set of experiments was performed in Ca# + -free medium. Thrombin (10 nM) caused an abrupt increase in [Ca# + ] i within 10 s, followed by a gradual decline to baseline over a period of 200 s (Figure 8a ), a response that was essentially identical in untransfected HEL cells, V-HEL cells and AS-HEL cells before exposure to IPTG. Exposure to IPTG for 1-5 days had no effect on Ca# + mobilization in V-HEL or untransfected HEL cells. In contrast, incubation of AS-HEL cells with IPTG for 1-5 days caused a marked and progressive decline in Ca# + mobilization (Figure 8b ). At lower thrombin concentrations (1-5 nM) which still effectively increased [Ca# + ] i in control cells, the response was greatly delayed in IPTG-treated AS-HEL cells and the majority of cells failed to respond at all (results not shown). Adding 1.8 mM Ca# + to the media, to determine the contribution of Ca# + influx, slightly increased, and more noticeably prolonged, the thrombin-induced rise of [Ca# + ] i in IPTG-treated V-HEL cells and untreated AS-HEL cells (Figure 8c ), but the response in IPTG-treated AS-HEL cells remained strongly suppressed (Figure 8d) .
To study further the mechanism(s) responsible for defective thrombin-induced Ca# + mobilization in AS-HEL cells we : (1) indirectly assessed the size of intracellular Ca# + stores by adding thapsigargin to cells in Ca# + -free medium, which releases ER Ca# + through its selective inhibition of the ER Ca# + pumps, i.e. SERCAs [29] , and (2) indirectly assessed the specific Ca# + influx that occurs upon restoring extracellular Ca# + to cells whose ER stores were first unloaded with thapsigargin [16] . It should be noted that the rise in [Ca# + ] i due to thapsigargin is slower and less in magnitude than that caused by thrombin, due to the different mechanisms responsible for Ca# + efflux, the possible existence of more than one releasable pool, and the opposing effect of Ca# + pumps and exchangers in the plasma membrane. From these experiments we determined that the thapsigargin-releasable pool of Ca# + was unaffected by the depletion of CHERP in IPTG-treated AS-HEL cells (Figures 9a  and 9b ) and that Ca# + influx induced by the unloading of internal stores was actually significantly greater in IPTG-treated AS-HEL cells (Figures 9c and 9d ). These findings demonstrate that the ability of thrombin to unload intracellular Ca# + stores is the most likely defective step in IPTG-treated AS-HEL cells, and that this defect occurs in conjunction with the loss of CHERP.
DISCUSSION
Using mAb213-21, which blocks InsP $ -induced Ca# + release from ER-derived membrane vesicles, we have cloned a cDNA for a novel protein, designated CHERP, that appears to be involved in the regulation of intracellular Ca# + homoeostasis. CHERP is an integral membrane protein localized to the InsP $ -sensitive fraction of the smooth ER derived from platelets and HEL cells [1, 2] .
The CHERP cDNA predicts a protein with a molecular mass of 100 kDa. Using HPLC chromatography, we previously identified proteins of 100 kDa and 63 kDa which reacted positively with the mAb213-21 [1,2]. Initially we were only able to purify significant quantities of the 63 kDa protein from platelet membranes, but subsequently we purified the 100 kDa protein as well (results not shown). In membrane extracts the 63 kDa protein increased over time as the 100 kDa protein decreased, suggesting that the former was derived as a breakdown product of the 100 kDa protein. The HEL cell proteins detected by mAb213-21 on Western blots migrate at M r 100 000 and 128 000, with the latter being the major band. Both 100 and 128 kDa bands were produced by in itro translation of the same cDNA, which suggests that the larger product may be the result of posttranslational modification, such as phosphorylation. Similarly, the expressed 2.6 kDa fragment of CHERP, which contains the serine\arginine domain, also migrates as a 20 % larger protein on SDS gels. Other proteins with extended serine\arginine regions like CHERP have been shown to exhibit large mobility shifts on SDS gels due to hyper-phosphorylation [30] .
To study the role of CHERP in intact cells, we produced a stable HEL cell line by transfection with a vector containing an antisense CHERP cDNA construct under the control of an inducible promoter. In response to IPTG, which relieves lacI repression of the promoter, CHERP was progressively reduced by 80 % in AS-HEL cells over a period of five days. Cells also increased in size and in adhesion to culture vessels, their rate of proliferation decreased dramatically, and subsequently they displayed a senescent-like phenotype. Concurrently, Ca# + mobilization by thrombin was markedly reduced. These changes all occurred without alteration of cell viability, or significant change in expression of the InsP $ receptor, SERCA2 and SERCA3, or the thrombin receptor.
After five days exposure to IPTG, the ability of thrombin to mobilize intracellular Ca# + was greatly suppressed and was totally lost in many cells at lower concentrations of the agonist. This defective mobilization of Ca# + , observed in Ca# + -free medium was not rectified by restoration of external Ca# + , indicating that influx was also defective. Further investigation revealed that the thapsigargin-releasable pool of internal Ca# + was unchanged in AS-HEL cells before and after five days treatment with IPTG, indicating that a deficit in this Ca# + store was unlikely to be the cause of the defective response to thrombin. In addition, the influx of Ca# + after first unloading Ca# + stores with thapsigargin, which bypasses the need for InsP $ , shows that influx is normal provided the ER stores are first unloaded, and that the defect in agonist-induced unloading of Ca# + stores is most likely to be responsible for the accompanying deficit in influx after thrombin. This is in agreement with current views on the intimate link between internal Ca# + stores and Ca# + entry [16, 31, 32] . Furthermore, our results are in close agreement with the findings of Somasundaram et al. [31] , specifically in HEL cells, where thrombin-induced Ca# + influx occurred entirely as a result of store-activated Ca# + current, that thapsigargin and thrombin released the same internal Ca# + store, and that the level of expression of store-activated Ca# + current probably determines the duration of thrombin-induced increase of [Ca# + ] i . We noted that Ca# + influx in IPTG-treated AS-HEL cells after thapsigargin was actually enhanced in IPTG-treated AS-HEL cells. We suggest that this is perhaps a compensatory response of the cultured cells experiencing decreased Ca# + mobilization by serum growth factors. It may be mediated by a decrease in the plasma membrane Ca# + -ATPase pump, or more likely by an increase in storeactivated Ca# + current [31] , and\or inward rectifying plasma membrane K + channels that we recently showed could enhance Ca# + influx after the unloading of ER stores [16] .
A link between defective Ca# + mobilization and arrest of cell proliferation is likely, since a sustained rise in [Ca# + ] i is necessary for the G1\S and G2\M phase transitions during cell division (reviewed in [33] ). In our studies, treatment with IPTG to induce expression of antisense message led to a reduction in proliferation of AS-HEL cells comparable with that observed when HEL cells were treated with cell-permeant BAPTA-acetoxymethyl ester to chelate intracellular Ca# + (results not shown). The IPTG-treated AS-HEL cells showed a two-thirds decline in the number of cells in S phase, as measured by [$H]thymidine incorporation into DNA. IPTG had only a minor effect on either untransfected HEL or V-HEL cells. These findings show that AS-HEL cells lacking CHERP fail to progress through the cell cycle, possibly because they cannot sustain Ca# + signals that are adequate for passage through the cellular checkpoints.
The specific molecular functions of CHERP have yet to be determined ; however, studies with mAb213-21 [2] and K + channel blockers and K + ionophores [2, 3] suggest that CHERP may be involved in regulating a K + conductance in the ER membrane. Ca# + release from permeabilized cells and microsomal vesicles require monovalent cations, with K + being the preferred cation in most cases [2, 34, 35] . K + influx may prevent a counterproductive ER transmembrane potential change brought about by Ca# + efflux from the ER [36] . Perhaps more importantly, K + influx also potentiates Ca# + release by displacing bound Ca# + from lumenal Ca# + -binding ion-exchange storage proteins, thereby greatly increasing the pool of free Ca# + that can flow through opened Ca# + channels [3] .
No ER or sarcoplasmic reticulum K + channel proteins have been sequenced to date, and we have no direct evidence that CHERP mediates K + transport in the ER. CHERP lacks an S4 TM present in voltage-sensitive channels [37] , and the C-terminal calmodulin-binding domain of many plasma membrane Ca# + -activated K + channels [38] . However, CHERP does have a GLG motif in the region between TM1 and TM2, which is considered to be one of the signature motifs of K + pores [21] [22] [23] , e.g. G(Y\F\L)G [22] .
CHERP appears to be a single-copy gene, so that a gain-or loss-of-function mutation could alter specific cellular functions controlled by Ca# + . CAG triplet repeats, as found in CHERP, are expanded in genes associated with Huntington 's disease, spinobulbar muscular atrophy and spinocerebellar ataxia types 1, 2, 3, 6 and 7 [18, [39] [40] [41] [42] . Some of these genes are specifically involved in regulating cytosolic Ca# + concentration, such as the human K + channel hKCa3\KCNN3 [39] , and the human α1A subunit of a voltage-dependent (P\Q-type) Ca# + -channel gene, the apparent cause of autosomal-dominant cerebellar ataxia type 6 [40] . In preliminary studies of blood cells from human donors we have not found any polymorphism in the CAG repeat in the CHERP gene (results not shown). The presence of the single CAA within the region, i.e. (CAG) ' CAA(CAG) & , can prevent mutational expansion. However, the 1-3 intervening CAAs in the midst of a CAG repeat in the spinocerebellar ataxia 2 (ataxin) [40] , or the CAT codons that interrupt the spinocerebellar ataxia 1 locus [42] can be mutated to CAG, permitting eventual elongation of the CAG domains with resulting pathology [41, 42] . The possibility that CHERP may undergo similar mutations that affect its function will require additional study. In conclusion, CHERP is a highly novel human protein colocalized with the InsP $ receptor in the ER membrane. It is distinguished by a polyglutamine tract and several potential domains for macromolecular assembly, and consensus phosphorylation sites for kinases regulated by a number of important signal transduction pathways. Suppression of its expression by antisense cDNA leads to functional changes that are consistent with prior evidence that demonstrate the protein plays an important role in the regulation of intracellular Ca# + mobilization [2] . 
